NeuroMetrix, Inc. (NURO): Price and Financial Metrics

NeuroMetrix, Inc. (NURO)

Today's Latest Price: $4.36 USD

0.62 (-12.45%)

Updated Jan 27 3:39pm

Add NURO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 485 in Biotech

See all "A" rated Strong Buy stocks

NURO Stock Summary

  • With a market capitalization of $18,847,592, NeuroMetrix Inc has a greater market value than only 5.5% of US stocks.
  • Revenue growth over the past 12 months for NeuroMetrix Inc comes in at -35.59%, a number that bests merely 9.22% of the US stocks we're tracking.
  • NeuroMetrix Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -22.07%, greater than the shareholder yield of merely 12.1% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to NeuroMetrix Inc, a group of peers worth examining would be XONE, HTGM, SRTS, SONM, and ULBI.
  • NURO's SEC filings can be seen here. And to visit NeuroMetrix Inc's official web site, go to

NURO Stock Price Chart Interactive Chart >

Price chart for NURO

NURO Price/Volume Stats

Current price $4.36 52-week high $6.20
Prev. close $4.98 52-week low $0.81
Day low $4.18 Volume 567,930
Day high $4.79 Avg. volume 605,886
50-day MA $2.87 Dividend yield N/A
200-day MA $2.21 Market Cap 16.50M

NeuroMetrix, Inc. (NURO) Company Bio

NeuroMetrix Inc. is a medical device company that designs, develops and sells proprietary products used to diagnose neuropathies. The Company's neuropathy diagnostic system provides primary care and specialist physicians objective information that aids in the diagnosis of neuropathies at the point of service.

NURO Latest News Stream

Event/Time News Detail
Loading, please wait...

NURO Latest Social Stream

Loading social stream, please wait...

View Full NURO Social Stream

Latest NURO News From Around the Web

Below are the latest news stories about NeuroMetrix Inc that investors may wish to consider to help them evaluate NURO as an investment opportunity.

Smart Medical Devices Market Prophesied to Grow at a Faster Pace by 2027 | Abbott Laboratories, Apple, Inc., Medtronic, Dexcom, Fitbit, F. Hoffmann-La Roche, Johnson & Johnson, Medtronic, NeuroMetrix, Samsung Electronics, and Sonova International

Increasing launch of wearable medical devices is expected to propel growth of Asia Pacific smart medical devices market over the forecast period. For instance, in January 2020, VivaLNK, a China-based provider of connected healthcare solutions for in-patient and remote patient

OpenPR | January 22, 2021

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2020 Financial Results Conference Call

WOBURN, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. The Company will host a conference call at 8:00 a.m., Eastern Time on January 28, 2021 to discuss its financial results as well as business developments affecting the Company. The conference call may be accessed in the United States by dialing 844-787-0799 and using the confirmation code 8694435. Internationally, the conference call may be accessed by dialing 661-378-9630 and using the same confirmation code. The earnings press release and accompanying condensed financial statements will be accessible from the Company's website at under the...

Yahoo | January 22, 2021

Internet-of-Medical-Things Market is expected to see growth rate of 38.67% | Medtronic, NeuroMetrix, Meru Health

Global Internet-of-Medical-Things Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, players market shares, and strategies that are key in the market. The exploration

OpenPR | January 15, 2021

Diabetic Neuropathy Market Growing Demands Globally in Forecasted Period 2020-2025 | Top Players: J&J, GSK, Boehringer Ingelheim, NeuroMetrix, Pfizer, Lupin, Astellas Pharma, Glenmark Pharmaceuticals

This report provides in-depth study on the current state of the Global Diabetic Neuropathy Market 2020-2025. Key players in the Global Diabetic Neuropathy Market have been identified through the secondary research and their market share has been determined through primary

OpenPR | December 15, 2020

40 Stocks Moving in Tuesday's Pre-Market Session

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) rose 85.6% to $3.99 in pre-market trading after climbing over 9% on Monday. Gran Tierra Energy Inc. (NYSE: GTE) …

Benzinga | December 8, 2020

Read More 'NURO' Stories Here

NURO Price Returns

1-mo 19.78%
3-mo 190.67%
6-mo 120.20%
1-year 36.25%
3-year -75.23%
5-year -96.66%
YTD 37.97%
2020 -26.51%
2019 -43.42%
2018 -56.04%
2017 -70.79%
2016 -62.63%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7467 seconds.